Select a Region North America

Unlocking the Power of Data, Artificial Intelligence and Digital Innovations to Revolutionize Care for Rare Disease Patients

Rare diseases and developing and distributing the therapies that treat them create highly complex challenges for pharmaceutical manufacturers, and certainly for the patients and providers impacted by them every day. Because these diseases are often extremely difficult to diagnose and treat effectively, advancements toward alleviating the toll they take on patients’ lives are often few and far between.

However, the merging of healthcare and advancing technology, specifically Artificial Intelligence (AI) and Machine Learning (ML), has given rise to a new sense of hope and progress in the rare disease community.

AI and ML have the ability to analyze extensive amounts of real-world data and uncover previously unknown patterns and insights to inform groundbreaking research, resulting in expansive improvements in diagnosis and overall care in the rare disease field.

In this latest article from Maria Kirsch, Scott Snyder, Faruk Abdullah and Pierantonio Russo, discover how these advancements in AI and ML, in conjunction with dedicated individuals committed to bettering the lives of patients, are redefining how the industry approaches the complexities of rare diseases while enhancing the patient journey for millions.

Maria Kirsch
President, Patient Services

Maria Kirsch is a decisive, strategic and forward-thinking leader with more than 20 years of experience across operational excellence and strategic development in the pharmaceutical industry. She previously served as Head of Patient Experience,…

Scott Snyder
Chief Digital Officer

Scott serves as EVERSANA’s Chief Digital Officer, driving digital transformation for employees, clients, and the patients we serve. He brings more than 30 years of experience in emerging technologies and digital transformation across both…

Faruk Capan
Chief Innovation Officer & Chief Executive Officer, EVERSANA INTOUCH

Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,500 employees globally that joined EVERSANA in December 2021. Faruk…

Pierantonio Russo, MD, FCPP, FAAP, STS
Corporate Chief Medical Officer

After leaving the Mayo Clinic, from 1988 to 2007, he held academic, clinical and administrative leadership positions as Chief of Cardiac Surgery, Pediatric Cardiac Surgery and Heart Transplantation  at several Academic Hospitals in the…